Independent Advisor Alliance’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,149
Closed -$304K – 726
2021
Q4
$304K Sell
1,149
-76
-6% -$20.5K 0.02% 523
2021
Q3
$354K Buy
1,225
+10
+0.8% +$2.56K 0.02% 448
2021
Q2
$243K Buy
1,215
+113
+10% +$21.9K 0.01% 549
2021
Q1
$214K Buy
1,102
+10
+0.9% +$2.05K 0.01% 546
2020
Q4
$209K Buy
+1,092
New +$199K 0.01% 503
2020
Q1
– Sell
-10,570
Closed -$978K – 763
2019
Q4
$978K Buy
+10,570
New +$888K 0.04% 368

Other funds holding RGEN

Independent Advisor Alliance's RGEN Position: Q1 2022 in Review

Independent Advisor Alliance sold out of Repligen (RGEN) in Q1 2022, closing a stake of 1,149 shares — an estimated $304K sold.

Independent Advisor Alliance first reported a position in RGEN in Q4 2019 and held it in 6 quarters. The position peaked at $978K in Q4 2019. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Independent Advisor Alliance reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Independent Advisor Alliance sold 1,149 Repligen shares in Q1 2022, an estimated $304K.
  • Independent Advisor Alliance first reported a position in Repligen in Q4 2019 and held it in 6 quarters.
  • Independent Advisor Alliance's Repligen position peaked at $978K in Q4 2019.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Independent Advisor Alliance's 13F filing for Q1 2022, filed 6 May 2022.